Compressive strain of improved red clay. حسب Quan Shen (37564)

الموضوعات:

Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

General procedure for the synthesis of A and A-c1. حسب Xueqin lu (22250795)

الموضوعات:

Average days to heal a wound in 2022 and 2023. حسب Heba Tallah Mohammed (2822432)

الموضوعات:

Wear morphology: (a) UT, (b) SP1, (c) SP2, and (d) SP3. حسب Huashen Guan (20454677)

الموضوعات:

Residual stress of various samples: (a) surface residual stress and (b) residual stress in the depth direction. حسب Huashen Guan (20454677)

الموضوعات:

Improvement effect of lactoferrin and Coenzyme Q10 on body composition of mice with sarcopenia. حسب Wenbin Wu (292223)

الموضوعات:

Average days (mean) to heal a wound in 2022 and 2023. حسب Heba Tallah Mohammed (2822432)

الموضوعات:

Microstructure of various samples: (a) UT, (b) SP1, (c) SP2, and (d) SP3. حسب Huashen Guan (20454677)

الموضوعات:

Data Sheet 1_Elevated relative humidity significantly decreases cannabinoid concentrations while delaying flowering development in Cannabis sativa L..docx حسب Ingrid Carolina Corredor-Perilla (22631510)

"…Furthermore, high RH significantly suppressed cannabinoid accumulation: cannabidiolic acid (CBD-A), cannabidiol (CBD), and cannabichromenic acid (CBC-A) levels decreased by approximately 4.9-fold, 3.2-fold, and 13-fold, respectively. …"

Surface 3D topography (a) UT, (b) SP1, (c) SP2, (d) SP3. حسب Huashen Guan (20454677)

الموضوعات:

Friction coefficients of various samples: (a) UT, (b) SP1, (c) SP2, and (d) SP3. حسب Huashen Guan (20454677)

الموضوعات:

Wear morphology of the SP samples: (a) (b) SP1, (c) (d) SP2, and (e)(f) SP3. حسب Huashen Guan (20454677)

الموضوعات: